Gene therapy for dyslipidemia: Clinical prospects
- 1 July 1999
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 1 (1) , 58-69
- https://doi.org/10.1007/s11883-999-0051-5
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Adenovirus-Mediated Gene Transfer of Human Lipoprotein Lipase Ameliorates the Hyperlipidemias Associated with Apolipoprotein E and LDL Receptor Deficiencies in MiceHuman Gene Therapy, 1997
- A mutation in the lipoprotein lipase gene is the molecular basis of chylomicronemia in a colony of domestic cats.Journal of Clinical Investigation, 1996
- Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Overexpression of Human Lipoprotein Lipase Protects Diabetic Transgenic Mice From Diabetic Hypertriglyceridemia and HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Phenotypic Correction of Hypercholesterolemia in ApoE-Deficient Mice by Adenovirus-Mediated In Vivo Gene TransferArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Indications for low-density lipoprotein apheresisThe American Journal of Cardiology, 1994
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery DiseaseNew England Journal of Medicine, 1982